Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

The 'biohacking' trend that has tech workers experimenting on themselves

Дата публикации: 19-01-2026 11:00:00


In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The hot new biohacking trend is injectable peptides — similar to the ones found in GLP-1 medications like Ozempic. But these are not approved by the Food and Drug Administration.These gray-market peptides, largely from Chinese manufacturers, are being used by tech workers and founders. Not just to lose weight, but to optimize their health and performance in all manner of ways. “Marketplace Tech” host Meghan McCarty Carino speaks with independent journalist Jasmine Sun, who recently wrote about this for the New York Times.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Startups are betting on a legalized peptide market0726-05-2026
2Beyond the Jab: The Surprising New Frontiers of GLP-1 Therapy014.1324-07-2026
3What AI fitness apps can and can't do — for now0504-02-2026
4Decoding the evidence on peptides, from topicals to longevity2609-07-2026
5Bytes: Week in Review - Anthropic and the Pentagon face off, OpenAI teams up with consulting firms and Mac Mini moves to the U.S.0527-02-2026
6Why SpaceX stock soared, then stumbled0726-06-2026
7БАДам под Ozempic прописали выход в онлайн // Насколько опасны имитации препаратов для похудения-2726-06-2026
8If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It0510-07-2026
9People On GLP-1s Like Ozempic And Zepbound Are Sharing The Surprise Benefits They Never Saw Coming, And Some Of These Genuinely Surprised Me010.4124-07-2026
10It's a tough time to break into cybersecurity-2515-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.marketplace.org.